AI-generated summary
The authors report two prospective clinical trials of low-energy laser therapy for oral mucositis in cancer patients receiving chemotherapy. In one study, 26 patients had a reported success rate of 81% when laser was given preventively, and in a randomized study of 36 patients with existing lesions the success rate was 83% versus 11% with sham treatment.
- Studies included
- 2
- Who or what was studied
- Cancer patients receiving chemotherapy, including those with various solid tumors and those with hematological tumors
- Limits stated in the abstract
- The abstract reports small sample sizes across two studies, and it does not specify the laser wavelength or the methods used to assess certainty of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Laser, Sham, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.